Published in Hum Psychopharmacol on October 01, 2003
Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev (2005) 14.71
Melioidosis. N Engl J Med (2012) 6.94
Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain (2007) 6.39
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol (2013) 5.73
Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement (2010) 4.85
Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei. J Clin Microbiol (2006) 2.94
Phylogeographic reconstruction of a bacterial species with high levels of lateral gene transfer. BMC Biol (2009) 2.94
The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals. J Int Neuropsychol Soc (2003) 2.83
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr (2009) 2.54
Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol (2009) 2.34
Nonrandom distribution of Burkholderia pseudomallei clones in relation to geographical location and virulence. J Clin Microbiol (2006) 2.34
Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis (2004) 2.33
High-dose baclofen for treatment-resistant alcohol dependence. J Clin Psychopharmacol (2012) 2.27
Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg Infect Dis (2008) 2.24
Clinical toxinology--where are we now? J Toxicol Clin Toxicol (2003) 2.23
Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes. J Infect Dis (2009) 2.20
Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis (2006) 2.18
Determining the extent of cognitive change after coronary surgery: a review of statistical procedures. Ann Thorac Surg (2002) 2.17
Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis (2006) 1.94
Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals. J Clin Exp Neuropsychol (2006) 1.92
The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn (2005) 1.91
Isolates of Burkholderia pseudomallei from Northern Australia are distinct by multilocus sequence typing, but strain types do not correlate with clinical presentation. J Clin Microbiol (2004) 1.88
Indirect hemagglutination assay in patients with melioidosis in northern Australia. Am J Trop Med Hyg (2006) 1.82
A horizontal gene transfer event defines two distinct groups within Burkholderia pseudomallei that have dissimilar geographic distributions. J Bacteriol (2007) 1.82
Genomic islands from five strains of Burkholderia pseudomallei. BMC Genomics (2008) 1.82
Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev (2007) 1.81
Murray Valley encephalitis: a review of clinical features, diagnosis and treatment. Med J Aust (2012) 1.77
CogSport: reliability and correlation with conventional cognitive tests used in postconcussion medical evaluations. Clin J Sport Med (2003) 1.76
Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clin Infect Dis (2013) 1.76
Landscape changes influence the occurrence of the melioidosis bacterium Burkholderia pseudomallei in soil in northern Australia. PLoS Negl Trop Dis (2009) 1.74
Systematic review and consensus guidelines for environmental sampling of Burkholderia pseudomallei. PLoS Negl Trop Dis (2013) 1.72
Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection. MBio (2013) 1.66
A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis (2007) 1.64
Sensitive and specific molecular detection of Burkholderia pseudomallei, the causative agent of melioidosis, in the soil of tropical northern Australia. Appl Environ Microbiol (2007) 1.62
Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity. J Infect Dis (2002) 1.60
Antiretroviral therapy in HIV infection: are neurologically active drugs important? Arch Neurol (2004) 1.59
Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clin Infect Dis (2011) 1.57
Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology (2006) 1.56
Genetic diversity of Burkholderia pseudomallei isolates in Australia. J Clin Microbiol (2007) 1.56
Research workshop to research work: initial steps in establishing health research systems on Malaita, Solomon Islands. Health Res Policy Syst (2010) 1.55
Dengue and climate change in Australia: predictions for the future should incorporate knowledge from the past. Med J Aust (2009) 1.55
Irukandji syndrome case series from Australia's Tropical Northern Territory. Ann Emerg Med (2009) 1.54
Tandem repeat regions within the Burkholderia pseudomallei genome and their application for high resolution genotyping. BMC Microbiol (2007) 1.54
Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease. BMC Bioinformatics (2014) 1.53
Sleep following sport-related concussions. Sleep Med (2008) 1.52
The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction. Int J Neuropsychopharmacol (2012) 1.52
Vibrio vulnificus and V. parahaemolyticus necrotising fasciitis in fishermen visiting an estuarine tropical northern Australian location. J Infect (2006) 1.51
Disease burden and health-care clinic attendances for young children in remote aboriginal communities of northern Australia. Bull World Health Organ (2008) 1.51
A very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment staphyloxanthin. Genome Biol Evol (2011) 1.51
Plasma amyloid beta42 and amyloid beta40 levels are associated with early cognitive dysfunction after cardiac surgery. Ann Thorac Surg (2009) 1.50
Preexisting cognitive impairment is associated with postoperative cognitive dysfunction after hip joint replacement surgery. Anesthesiology (2015) 1.50
Clonality and recombination in genetically differentiated subgroups of Cryptococcus gattii. Eukaryot Cell (2005) 1.48
Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J Clin Microbiol (2007) 1.48
Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010. Emerg Infect Dis (2012) 1.48
Outcomes of patients with melioidosis treated with meropenem. Antimicrob Agents Chemother (2004) 1.48
Cutaneous melioidosis in the tropical top end of Australia: a prospective study and review of the literature. Clin Infect Dis (2008) 1.48
The influence of different error estimates in the detection of postoperative cognitive dysfunction using reliable change indices with correction for practice effects. Arch Clin Neuropsychol (2007) 1.47
Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis. Clin Infect Dis (2003) 1.44
Extreme weather events and environmental contamination are associated with case-clusters of melioidosis in the Northern Territory of Australia. Int J Epidemiol (2005) 1.43
Use of a single-nucleotide polymorphism genotyping system to demonstrate the unique epidemiology of methicillin-resistant Staphylococcus aureus in remote aboriginal communities. J Clin Microbiol (2006) 1.43
Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole? J Clin Microbiol (2012) 1.42
Return to Work and Functional Outcomes After Major Trauma: Who Recovers, When, and How Well? Ann Surg (2016) 1.42
The Global Evidence Mapping Initiative: scoping research in broad topic areas. BMC Med Res Methodol (2011) 1.41
Pneumonia risk stratification in tropical Australia: does the SMART-COP score apply? Med J Aust (2010) 1.41
VNTR analysis of selected outbreaks of Burkholderia pseudomallei in Australia. Infect Genet Evol (2006) 1.40
Differences in motor imagery between children with developmental coordination disorder with and without the combined type of ADHD. Dev Med Child Neurol (2008) 1.40
Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol (2002) 1.39
Lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins. Am J Trop Med Hyg (2006) 1.39
Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev (2006) 1.37
Melioidosis in northern Australia, 2001-02. Commun Dis Intell Q Rep (2003) 1.37
A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl Trop Dis (2009) 1.35
Homonymous visual field defects and stroke in an older population. Stroke (2002) 1.35
Cystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem? Clin Infect Dis (2002) 1.35
Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology (2012) 1.31
Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease. Brain (2013) 1.31
Clinical correlates of Panton-Valentine leukocidin (PVL), PVL isoforms, and clonal complex in the Staphylococcus aureus population of Northern Australia. J Infect Dis (2010) 1.29
A validation of the post concussion symptom scale in the assessment of complex concussion using cognitive testing and functional MRI. J Neurol Neurosurg Psychiatry (2007) 1.29
Scabies: new future for a neglected disease. Adv Parasitol (2004) 1.29
Melioidosis at Royal Darwin Hospital in the big 2009-2010 wet season: comparison with the preceding 20 years. Med J Aust (2012) 1.29
Burkholderia pseudomallei genome plasticity associated with genomic island variation. BMC Genomics (2008) 1.28
Group A streptococci from a remote community have novel multilocus genotypes but share emm types and housekeeping alleles with isolates from worldwide sources. J Infect Dis (2004) 1.27
Postoperative cognitive dysfunction is independent of type of surgery and anesthetic. Anesth Analg (2011) 1.27
Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med J Aust (2006) 1.27
The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol (2005) 1.26
Behavioural studies of spatial working memory dysfunction in schizophrenia: a quantitative literature review. Psychiatry Res (2007) 1.26
Epidemiology of Streptococcus dysgalactiae subsp. equisimilis in tropical communities, Northern Australia. Emerg Infect Dis (2007) 1.26
Natural history of concussion in sport: markers of severity and implications for management. Am J Sports Med (2010) 1.26
Assessing cognitive function in cancer patients. Support Care Cancer (2006) 1.25
Epidemiology of community-acquired and nosocomial bloodstream infections in tropical Australia: a 12-month prospective study. Trop Med Int Health (2004) 1.24
Clinical definitions of melioidosis. Am J Trop Med Hyg (2013) 1.24
Qualitative similarities in cognitive impairment associated with 24 h of sustained wakefulness and a blood alcohol concentration of 0.05%. J Sleep Res (2003) 1.22
Inter-species genetic movement may blur the epidemiology of streptococcal diseases in endemic regions. Microbes Infect (2005) 1.22
Clinical evaluation of a type III secretion system real-time PCR assay for diagnosing melioidosis. J Clin Microbiol (2006) 1.20
Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. J Clin Exp Neuropsychol (2012) 1.18
Prevalence and sequence diversity of a factor required for actin-based motility in natural populations of Burkholderia species. J Clin Microbiol (2008) 1.18
A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia. J Clin Exp Neuropsychol (2009) 1.17
Contamination of hand wash detergent linked to occupationally acquired melioidosis. Am J Trop Med Hyg (2004) 1.16
Global implications of the emergence of community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations. Clin Infect Dis (2008) 1.16
Rehabilitation strategies for patients with homonymous visual field defects. J Neuroophthalmol (2005) 1.16